Fabrazyme
Active substance: agalsidase beta
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · AGALSIDASE BETA 5 mg/mL
United StatesActive
Marketing holder: Genzyme Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- AGALSIDASE BETA · 5 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-7e33-7816-8270-d3bd0782ef78,01a12098-db07-7407-8962-3fa3886dedfe;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 58468-0041
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 58468-0041 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58468-0041 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58468-0041 · Verified 2026-10-09 · open in source